Celldex Therapeutics, Inc.
CLDX
$21.75
-$0.18-0.82%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -6.38% | -7.17% | -4.06% | -5.77% | -2.61% |
| Total Receivables | -91.54% | 52.00% | -17.84% | -44.46% | -42.57% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -7.34% | -8.39% | -3.70% | 170.69% | -7.76% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -6.54% | -7.15% | -4.07% | -4.08% | -2.80% |
|
|
|||||
| Total Current Assets | -6.54% | -7.15% | -4.07% | -4.08% | -2.80% |
| Net Property, Plant & Equipment | -7.42% | -1.56% | 11.41% | 17.20% | 1.41% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -10.65% | 6.79% | 0.00% | 9,009.35% | 0.00% |
| Total Assets | -6.36% | -6.67% | -3.75% | -2.65% | -2.68% |
|
|
|||||
| Total Accounts Payable | -39.21% | 4.44% | 193.09% | -70.70% | 17.56% |
| Total Accrued Expenses | 11.66% | -24.78% | 19.99% | 51.68% | 6.03% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.47% | 3.24% | 5.29% | -13.22% | -3.35% |
| Total Finance Division Other Current Liabilities | -43.74% | 75.48% | -32.52% | -61.99% | -5.26% |
| Total Other Current Liabilities | -43.74% | 75.48% | -32.52% | -61.99% | -5.26% |
| Total Current Liabilities | 2.95% | -18.94% | 23.08% | 16.04% | 5.20% |
|
|
|||||
| Total Current Liabilities | 2.95% | -18.94% | 23.08% | 16.04% | 5.20% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -22.50% | -18.30% | 38.23% | 114.57% | 69.36% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 0.00% | -26.78% | 0.00% | 0.00% | 0.00% |
| Total Liabilities | 1.40% | -19.51% | 21.63% | 16.75% | 5.60% |
|
|
|||||
| Common Stock & APIC | 0.40% | 0.41% | 0.44% | 0.48% | 0.50% |
| Retained Earnings | -3.52% | -3.46% | -3.12% | -2.87% | -2.51% |
| Treasury Stock & Other | -6.42% | 7.66% | -37.33% | 197.08% | -20.68% |
| Total Common Equity | -6.77% | -5.89% | -4.95% | -3.41% | -2.98% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -6.77% | -5.89% | -4.95% | -3.41% | -2.98% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -6.77% | -5.89% | -4.95% | -3.41% | -2.98% |
|
|
|||||